Posted by Stacy Sanders on Nov 13th, 2024
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Free Report) – Investment analysts at HC Wainwright issued their Q1 2025 earnings estimates for shares of Corbus Pharmaceuticals in a research report issued on Thursday,...
More of this article »